|
|
Key Messages on Safer Supply: The NSS-CoP has assembled key messages on safer supply as well as a series of infographics and social media campaign packages. Updates to these key messages will happen on an ongoing basis as more research, evidence, and information emerges. Check it out now!
|
|
Black Feminist Approach to Ending the Drug War – Interrupting Criminalization, Drug Policy Alliance & In Our Names: Building a Black feminist approach to ending the drug war offers an opportunity for organizers and advocates to come together across movements and borders to build a shared analysis and a common agenda shaped by the experiences and visions of Black women, girls, and trans people around the world. This document summarizes the key facts, statistics, and elements of Black Feminist Visions to End the Drug War surfaced during this gathering. This framework is intended as a contribution to these and ongoing efforts to articulate and advance a transnational Black feminist agenda to end the drug war rooted in the experiences, resistance, and dreams of Black women, girls, and trans and gender-nonconforming people. Download it here!
Episode 41 and Episode 42 Part 1 - Crackdown Podcast: Two new episodes of Crackdown Podcast were released this month. Listen now to Episode 41: New Front, Old War and to Episode 42: Kids on the Block Part 1 - Bones.
Survey on Safer Supply in Quebec, 2023 - L'équipe de soutien clinique et organisationnel en dépendance et itinérance (ESCODI), la communauté de pratique médicale en dépendance (CPMD) & Direction régionale de santé publique de Montréal: Check out the results of the latest ESCODI survey, in collaboration with CPMD and DRSP de Montréal, on Safer Supply in Quebec. Download it in English and in French.
Opioid Use, Related Harms, and Access to Treatment Among First Nations in Ontario – ODPRN: The opioid overdose crisis has disproportionately impacted First Nations individuals in Ontario, Canada. Over the past several years, the Chiefs of Ontario (COO) and the Ontario Drug Policy Research Network (ODPRN) have been collaborating to study trends in opioid use and opioid-related poisoning among First Nations people in Ontario. This report builds on the results reported in the initial 2021 report and examines the trends and patterns in opioid prescribing, access to treatment, and opioid-related toxicity among First Nations in Ontario up to the end of 2021. Download the full report and download the infographic.
Episode #72 - The Toxic Drug Crisis Podcast Series: The Role of Safer Supply - CIAJ: Drug toxicity is a leading cause of death in Canada and around the world. Over the course of three episodes, we will address three interrelated topics related to the toxic drug crisis. This second episode will focus on how safe supply can help to combat the toxic drug crisis. From January to September 2022, fentanyl was involved in more than 81% of opioid toxicity deaths. Safer supply has the potential to mitigate the increasingly unpredictable state of street drugs. Host Sarah Rowe addresses this question and more with guests, public health researcher and postdoctoral fellow, Dr. Gillian Kolla, and addiction medicine physician, Dr. Sukhpreet Klaire.
Supervised Consumption Sites Dashboard – Health Canada: Data on supervised consumption sites (SCS) in Canada, including the number of visits, client demographics, client safety, drugs used and overdoses.
People Who Use Drugs (PWUD) Support Group: Tonya Evans and a group of other PWUD have started a support group for PWUD. It's a very open group that has no organization affiliation. They come together to support each other and advocate for each other. They meet on Tuesdays at 5pm ET. You can join using this Zoom Link. Passcode: drugs. If there are any questions, please email Tonya Evans: tonyat_29@hotmail.com.
|
|
NSS-CoP Resource Library: Did you know we have a resource library with OVER 1,500 resources on safer supply? You can access it for FREE anytime. It features academic journal articles, grey literature, knowledge translation materials, clinical practice guidelines, and more!
|
|
RESEARCH PAPER OF THE MONTH
|
|
|
Scow, M., et al. (2023). Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia | Harm Reduction Journal
Highlights:
- We outline a peer-led program focused on opioid agonist treatment and prescribed safe supply medication delivery that began in March 2020 at a clinic in rural BC.
- The peer has regular contact with approximately 50 clients and navigates medication delivery and appointments for approximately 10–15 people each day.
- Clients have been retained on the medication, and experienced improvement in other outcomes, including securing housing, employment and managing acute and chronic health conditions.
- The peer has established contact with clients since March 2020 to support engagement with health care and continuity of medication access.
- This program highlights the importance and value of peer-led work and need for further investments in peer-led programs to respond to the unregulated drug poisoning crisis.
|
|
Macevicius, C., et al. (2023). Just have this come from their prescription pad: the medicalization of safer supply from the perspectives of health planners in BC, Canada | Drugs: Education, Prevention and Policy
Perri, M., et al. (2023). A rapid review of current engagement strategies with people who use drugs in monitoring and reporting on substance use-related harms | Harm Reduction Journal
Frank, D., et al. (2023). As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids | Harm Reduction Journal
Butler, A., et al. (2023). The impact of COVID-19 on opioid toxicity deaths for people who experience incarceration compared to the general population in Ontario: A whole population data linkage study | PLoS One
Salvalaggio, G., et al. (2023). Flawed reports can harm: the case of supervised consumption services in Alberta | Canadian Journal of Public Health
Sue, K. L., et al. (2023). Clinical considerations for the management of xylazine overdoses and xylazine-related wounds | Addiction
Welwean, R. A., et al. (2023). Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices in North America: a Retrospective Study | Journal of Urban Health
Perdue, T., et al. (2023). Characterizing prescription opioid, heroin, and fentanyl initiation trajectories: A qualitative study | Social Science & Medicine
Iacono, A., et al. (2023). Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: a population-based cohort study in Ontario, Canada | Drug and Alcohol Dependence
Long, C., et al. (2023). The multiple makings of a supervised consumption service in a hospital setting | International Journal of Drug Policy
Friedmann, Z., et al. (2023). Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities | Harm Reduction Journal
Evans, E. A., et al. (2023). Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts | International Journal of Drug Policy
Parkin, S., et al. (2023). Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study | International Journal of Drug Policy
Goldshear, J. L., et al. (2023). “Notice of major cleaning”: A qualitative study of the negative impact of encampment sweeps on the ontological security of unhoused people who use drugs | Social Science & Medicine
Chalfin, A., et al. (2023). Overdose Prevention Centers, Crime, and Disorder in New York City | JAMA Network Open
McFadden, R., et al. (2023). Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia | Journal of Addiction Medicine
|
|
COMMUNITY UPDATES & EVENTS
|
|
|
We encourage NSS-CoP members to email info@nss-aps.ca with submissions to include in our newsletter. Content examples include but are not limited to community-led projects, webinars and events, peer-reviewed articles, grey literature, and more!
|
|
Examining Moral Distress in Health Care: A Panel Discussion on Ways Forward - RNAO: The Registered Nurses Association (RNAO) in partnership with the Harm Reduction Nurses Association (HRNA), Community Health Nurses’ Interest Group (CHNIG), Mental Health Nurses Interest Group (MHNIG), MOMS Stop the Harm and the National Safer Supply Community of Practice (NSS-CoP) invite you to join us for a webinar on the topic of "Examining Moral Distress in Health Care: A Panel Discussion on Ways Forward". Register here.
Date: Tuesday, December 12, 2023 1-2pm ET
Panelists:
- Corey Ranger, RN, BN. Clinical Nurse Specialist, AVI Health & Community Services and President, Harm Reduction Nurses Association
- Dr. Rosanra Yoon, MN, PhD, NP-Adult. Assistant Professor, Daphne Cockwell School of Nursing, Faculty of Community Services, Toronto Metropolitan University and Evaluation and QI Lead, Mid-West Toronto Ontario Health Team
- Jenna Bennett, RN, MPH student LSHTM, Harm Reduction Community Health Nurse
For more information, objectives of the webinar and to register: RNAO.ca/events/examining-moral-distress-in-health-care
|
|
Evolving models of supervised consumption services and overdose prevention sites in Canada - CATIE and Dr. Peter Centre: Supervised consumption services (SCS) and overdose prevention sites (OPS) provide people who use drugs with new harm reduction supplies and a safe, supervised space to use their drugs. As SCS and OPS have expanded rapidly across parts of Canada in recent years, new models have been developed and adapted according to changing community needs. This webinar will showcase different models of SCS and OPS, including innovative approaches to providing harm reduction services. It will aim to increase service providers’ understanding of the SCS and OPS landscape in Canada, as well as share a range of strategies that service providers can consider implementing to meet the needs of their communities. This webinar is presented in partnership with the Urgent Public Health Need Sites (UPHNS) HUB Community of Practice.
Date: Monday, December 4, 2023 1-2:30pm ET
Moderators: Cassandra Smith, Dr. Peter Centre, and Magnus Nowell, CATIE
Speakers:
- Jill Aalhus, Blood Ties Four Directions Centre
- Félix-Antoine Guérin, L’Anonyme
- Patrick McDougall, Dr. Peter Centre
- Ashley Smoke, Tweak Easy
- Lee Zorniak, Royal Alexandra Hospital
|
|
Mental Health and Substance Use Health (MHSUH) Integration in Primary Care Consultation Sessions - CSA: The Canadian Standards Association (CSA Group) invites you to join its consultation sessions and workshops on Mental Health and Substance Use Health (MHSUH) integration in Primary Care. CSA Group will be conducting these consultation sessions to gain insights from Canadians about their experiences and challenges with accessing and navigating Mental Health and Substance use health within primary care. The sessions will help inform guidance on how mental health, substance use health and primary care services can work better together. Please register by the date indicated for the consultation and workshop sessions (you may participate in more than one) here. Virtual consultation sessions are scheduled for the following dates:
- Healthcare Providers Session | Monday, December 4th, 2023 (2-4pm ET): Session for health care professionals and mental health experts, including those who are predominantly involved in the delivery of mental health and substance use health in the primary care and general health care setting (e.g., frontline staff, nurses, health care providers, social workers, physicians, family doctor, psychiatrists, peer workers etc.) This also includes experts involved in mental health and substance use health. (e.g., researchers, managers, administrators).
- Indigenous Communities Session | Thursday, December 7th, 2023 (1-3:30pm ET): Session for members of Indigenous Communities, including elders, persons with lived and living experiences, their families, and caregivers, as well as those who are predominantly involved in the delivery or management of primary care and mental health and substance use health for Indigenous Communities.
- Health Equity and Access Session | Monday, December 11th, 2023 (2-4pm ET): Session for representatives from organizations that are involved in health equity and access initiatives (e.g., LGBTQ2S+ organizations and communities, racialized communities’ health organizations, health equity researchers, etc.). This session will also include family and caregivers of individuals with lived and living experience to share their stories on mental health and substance use health access and equity.
- People with Lived and Living Experience Session | Wednesday, December 13th, 2023 (1-3:30pm ET): Session for people with lived and living experience of mental health and substance use. Registration deadline: TBD.
The virtual consultation sessions will culminate in a multi-stakeholder workshop on integration of MHSUH in primary care scheduled for:
- Multi-Stakeholder Workshop | Wednesday, January 10th, 2024 (1-4pm ET): Multi-stakeholder workshop to review input from enhanced engagement sessions and begin drafting content for the National Workshop Agreement.
Contact
Taurai Kurebwa
Project Manager Health Care and Well-being
CSA Group
Phone: 416 747 4000 ext. 42334
taurai.kurebwa@csagroup.org
|
|
National and General News:
British Columbia:
Alberta:
Saskatchewan:
Manitoba:
Yukon, Northwest Territories, and Nunavut:
Québec (et en français s'il vous plaît!):
Atlantic Region (Nova Scotia, New Brunswick, Prince Edward Island, Newfoundland and Labrador):
|
|
|
|
|
|